{
    "2020-03-27": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Covid-19 Could Benefit Generic Drug Companies",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Benefit",
                        "Generic",
                        "Drug",
                        "Companies"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-04-20",
                "original_text": "Novartis CEO Talks Coronavirus Vaccine Progress, Timeline",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "Coronavirus",
                        "Vaccine",
                        "Progress",
                        "Timeline"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-10",
                "original_text": "Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CEO",
                        "Cautions",
                        "Efficacy",
                        "Trump-Touted",
                        "Covid-19",
                        "Treatment"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}